-
HATIP #1, 13th March 2003
-
HATIP #2, 27th March 2003
-
HATIP #3, 10th April 2003
- HATIP #4, 24 April 2003
-
HATIP #5, 8 May 2003
-
HATIP #6, 23 May 2003
-
HATIP #7, 12 June 2003
- HATIP #8, 26 June 2003
-
HATIP #9, 10th July 2003
-
HATIP #10, 24 July 2003
-
HATIP #11, 7 August 2003
- HATIP #12, 28 August 2003
-
HATIP #13, 11 September 2003
-
HATIP #14, 2 October 2003
-
HATIP #15, 9 October 2003
- HATIP #16, 23 October 2003
- HATIP #17 , November 6 2003
- HATIP #18 24 November 2003
- HATIP #19, 4 December 2003
- HATIP #20, 19 December 2003
feedback
Give us your views on our work
HATIP #8, 26 June 2003
News headlines
A selection of news stories which have appeared since 12 June 2003
UNAIDS says US$4.7 billion to be spent on HIV in poorer countries in 2003, US$10.5 needed by 2005
Less than half of the US$10.5 billion needed for to address the AIDS epidemic in low and middle-income countries by 2005 will be spent on the epidemic in 2003, according to a UNAIDS published on June 26th.
EU fails to commit 1 billion euros to Global Fund
Despite, pressure from the United Kingdom, France and President Bush, EU leaders failed to commit to donating ¬1 billion euros to the Global Fund to Fight AIDS, TB and Malaria at last weekend's EU Summit in Greece, agreeing instead `to make a substantial contribution`. The formula was agreed because Germany, the Netherlands and several other smaller states said that they could not afford to give more support because of ongoing budgetary problems.
Adherence in Cape Town poor just as good as US and Europe
In South Africa, the presumption that indigent patients might not stick to pill-taking schedules has served as an excuse to delay the extension of antiretroviral treatment to the HIV-infected population. However, according to a study published in the June 12th edition of AIDS by Dr. Catherine Orrell et al., "adherence is not a barrier to successful antiretroviral therapy in South Africa."
TB checks in HIV care valuable for new mums in South Africa
Health care workers at the Chris Hani Baragwanath Hospital in Soweto, South Africa, have shown that offering routine TB checks for new mothers with HIV (and their male partners) can identify many previously unsuspected cases in need of treatment.
Private prescribing biggest risk for developing world drug resistance
Unless HIV treatment is properly controlled in developing countries, antiretroviral therapy could become useless due to poor practice in the private sector, according to an editorial in the June 21 edition of the British Medical Journal by Ruairi Brugha, a senior lecturer in public health at the London School of Hygiene and Tropical Medicine.
Three per cent of men who have sex with men HIV-positive in Beijing
Researchers from China and the USA suggest in this week's issue of The Lancet that men who have unprotected sex with men might worsen China's emerging HIV-1 epidemic because they form a sexual bridge between men and women.
Sex, not injections, drives HIV epidemic in Zimbabwe
In the last year, several researchers have challenged the view that the HIV epidemic in Southern Africa is the result of sexual transmission, arguing that poor medical practice and especially the re-use of syringes for injections - plays a bigger role than previously recognised. This claim is now strongly challenged in the journal AIDS by researchers working in Zimbabwe, based on a study of hepatitis C virus (HCV) prevalence among people living with HIV.
Exercise linked to lower triglyceride levels on HAART
People who exercise more show fewer signs of a major metabolic disturbance associated with HIV therapy elevated triglyceride levels - according to a study of 120 HIV-positive patients at Bostons Beth Israel Medical Centre, published this week in the June 15th edition of Clinical Infectious Diseases.
Diet changes successfully reduce cholesterol in HAART-treated patients
Diet modification can successfully reduce cholesterol levels in HAART-treated HIV-positive patients, according to a small study published in the June 13th edition of the journal AIDS.
Do cholesterol rises in HAART-treated men reflect normalisation, or treatment side-effect?
A US study published in the June 11th edition of the Journal of the American Medical Association suggests that the increases in cholesterol levels seen in HAART-treated patients represent a normalisation of total and LDL cholesterol levels rather than a harmful consequence of therapy.
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Multiple treatment failures occur less frequently but remain associated with high mortality rates in North American cohort
- People with HIV providing high quality treatment support in community
- International donors must not retreat from commitment to HIV treatment scale-up, MSF warns
- Reassurance for HIV-positive women about short-term risk of bone loss
- Circumcision protects gay men who have a 'preference' for insertive sex from HIV
- Certain manifestations of stigma especially hurtful for people with HIV
- GSK and Pfizer launch joint HIV venture, ViiV Healthcare
- New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection
- President Obama announces US HIV travel ban will end in January 2010
- Darunavir/ritonavir, etravirine and raltegravir combination has 'remarkable' success in children with resistant virus